Recent Updates
Recently added Catalysts
LIVN Positive Sentiment

LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September

Thursday, September 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: LivaNova PLC will present at the Morgan Stanley and Baird Healthcare Conferences in September. The presentations are scheduled for September 14 and 15 in New York City. CEO Vladimir Makatsaria and CFO Alex Shvartsburg will represent the company, highlighting its market-leading medical technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • LivaNova is actively participating in major healthcare conferences.
  • The presentations provide visibility for LivaNova's innovations.
  • Engagement with investors can enhance market confidence.

Full Press Release Details

GLOUCESTER, England--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the two following September healthcare conferences in New York City: Morgan Stanley 24th Annual Global Healthcare Conference on Mon., Sept. 14, from 11:30 a.m.-12:05 p.m. EDT Baird 2026 Global Healthcare Conference on Tues., Sept. 15, from 11:25-11:55 a.m. EDT Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial

Frequently Asked Questions

When will LivaNova present at the healthcare conferences?

LivaNova will present on September 14 and 15 at the conferences.

Who will represent LivaNova at the conferences?

CEO Vladimir Makatsaria and CFO Alex Shvartsburg will represent LivaNova.

Where are the conferences taking place?

The conferences will be held in New York City.

What is the focus of LivaNova's presentations?

LivaNova will showcase its market-leading medical technologies.

ShareAdd on Google
Tags: LIVN Viatris Investor Conferences Healthcare LivaNova Morgan Stanley Baird healthcare conference
Last updated: Sep 3, 2026

Biotech snapshot

Cash runway
$520M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CRT-SonR 9770Phase 3
Heart Failure →